http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9858629-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3dd1b8de190afa9b39258c99fcdf7f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a15faa1099de1b3d04ccd0bfe15371a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60672397b4466cedd388be8270971824
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
filingDate 1998-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa15d56c0de6c2c2168736b289040e56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1057c0d590d6ac07a8fa6e0881b4451
publicationDate 1999-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9858629-A3
titleOfInvention Preparation of pharmaceutical compositions
abstract A substantially homogenous composition for human administration comprises a biologically active lipophilic compound dissolved in or associated with at least one micelle-forming lipid. For example, cyclosporin A is dissolved or dispersed in the mixture of PC and MAPC. The composition may be made by dissolving the lipid material in ethanol, adding the lipophilic compound to the ethanol and removing the ethanol, after which the composition may be formulated for human oral administration.
priorityDate 1997-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9426254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-505983-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0117811-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0795585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8807362-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9833512-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754

Total number of triples: 45.